Hims & Hers Fell 16% Today. The Lilly Pop Is Gone
Hims & Hers (HIMS) fell about 16.5% on Tue, Nov 10, 2026, to about $19.15, losing almost $900M in market value in one day.
· 343 views · YouTube video: Hims & Hers Fell 16% Today. The Lilly Pop Is Gone
Watch on YouTube · Subscribe to @PROOFOFDATA
All 5 stock and crypto moves of November 10, 2026
Quick overview
- HIMS fell about 16.5% on Nov 10, 2026, to about $19.15, losing almost $900M in market value.
- Q3 gross margin dropped to 57% from 74% a year earlier, with a $66.1M operating loss.
- The 8% jump on Friday's Eli Lilly deal is gone; the stock is down about 26% since Friday's close.
- -16.5% HIMS on Nov 10, 2026 (close ~$19.15)
- 57% Q3 gross margin, down from 74% a year ago
- -26% Since Friday's close after the Lilly deal
What happened
On Friday, Nov 6, Hims & Hers rose about 8% after announcing a deal to offer Eli Lilly's Zepbound and Foundayo on its platform. By Tuesday's close (4:00 PM ET) the gain was gone: the stock fell about 16.5% in one day to roughly $19.15, according to Yahoo Finance prices and share counts.
That leaves HIMS down about 41% in 2026. Its record close was $68.74 on Feb 19, 2025; more than $11B in market value has disappeared since then.
Why it matters
The sell-off followed third-quarter numbers reported by Yahoo Finance, Benzinga and Invezz. Gross margin fell to 57% from 74% a year earlier, the company swung to an operating loss of $66.1M, and it cut its 2026 adjusted EBITDA outlook to $257–277M.
A new partnership can lift a stock for a day. Falling margins and a lower profit forecast weighed more with the market. Not financial advice.
Watch the 30-second breakdown on YouTube, with every number on screen.
FAQ
Why did Hims & Hers stock fall today?
HIMS fell about 16.5% on Nov 10, 2026, after third-quarter results showed gross margin falling to 57% from 74% a year earlier, an operating loss of $66.1M and a cut to its 2026 adjusted EBITDA outlook to $257–277M.
Watch on YouTube · Subscribe to @PROOFOFDATA
Topics: hims, hims stock, hims and hers, hims stock price, hims earnings, hims stock news, telehealth stocks, stock market today


